Yazar "Acikel, C." seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    ASSESSMENT OF CURRENT APPROACHES OF SURFACTANT REPLACEMENT THERAPY IN NEONATAL INTENSIVE CARE UNITS AMONG TURKEY: NATIONAL SURVEY
    (Springer, 2016) Tunc, T.; Polat, A.; Acikel, C.; Karadag, A.; Bas, A. Y.; Erdeve, O.; Koc, E.
    [Abstract Not Available]
  • Küçük Resim Yok
    Öğe
    Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children
    (Clinical & Exper Rheumatology, 2015) Yesilkaya, S.; Acikel, C.; Fidanci, B. E.; Polat, A.; Sozeri, B.; Ayaz, N. A.; Makay, B. B.
    Objective. To develop and assess the validity and reliability of an adherence scale concerning medical treatment in paediatric FMF patients. Methods. The Medication Adherence Scale in FMF Patients (MASIF) is a 18-item questionnaire that evaluates adherence to medication in four domains. Validation of the instrument was accomplished in paediatric FMF patients (aged 2-18 years) under medication at least for 6 months. The first step was to build up the scale through qualitative approach (with interviews using semi-structured questions). Validation analyses included assessment of feasibility, face and content validity; construct validity, internal consistency and test-retest reliability. Results. One hundred and fifty patients with FMF were enrolled in the study. The mean age of the patients was 11.11 +/- 4.02 years and 48.7% of them were male. The MASIF was found to be feasible and valid for both face and content. It correlated with the Morisky Medication Adherence Scale as a gold standard thereby demonstrating good construct validity (r=0.5 15, p<0.001). Assessment of content validity identified four subscales. The internal consistency, Cronbach's alpha was 0.728. There was a positive and significant correlation between test and retest scores (r-0.843; p<0.001). Also, a significant correlation between parents' and children's reports (r=0.781, p<0.001). Conclusion. Based on these results, the use of this scale to assess and follow up the adherence to treatment in paediatric FMF patients under medical treatment is recommended.
  • Küçük Resim Yok
    Öğe
    Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study
    (Elsevier Sci Ltd, 2013) Erdem, H.; Kilic, S.; Sener, B.; Acikel, C.; Alp, E.; Karahocagil, M.; Yetkin, F.
    No detailed data exist in the literature on the accurate diagnosis of chronic brucellar meningitis or meningoencephalitis. A multicentre retrospective chart review was performed at 19 health centres to determine sensitivities of the diagnostic tests. This study included 177 patients. The mean values of CSF biochemical test results were as follows: CSF protein, 330.64 +/- 493.28mg/dL; CSF/ blood-glucose ratio, 0.35 +/- 0.16; CSF sodium, 140.61 +/- 8.14mMt; CSF leucocyte count, 215.99 +/- 306.87. The sensitivities of the tests were as follows: serum standard tube agglutination (STA), 94%; cerebrospinal fluid (CSF) STA, 78%; serum Rose Bengal test (RBT), 96%; CSF RBT, 71%; automated blood culture, 37%; automated CSF culture, 25%; conventional CSF culture, 9%. The clinician should use every possible means to diagnose chronic neurobrucellosis. The high seropositivitiy in brucellar blood tests must facilitate the use of blood serology. Although STA should be preferred over RBT in CSF in probable neurobrucellosis other than the acute form of the disease, RBT is not as weak as expected. Moreover, automated culture systems should be applied when CSF culture is needed.